The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas

作者: Berta Segura-Collar , Ricardo Gargini , Elena Tovar-Ambel , Esther Hernández-SanMiguel , Carolina Epifano

DOI: 10.3390/CANCERS12010208

关键词:

摘要: Despite the high frequency of EGFR and TP53 genetic alterations in gliomas, little is known about their crosstalk during tumor progression. Here, we described a mutually exclusive distribution between mutations these two genes. We found that wild-type p53 gliomas are more aggressive than mutant counterparts, probably because former accumulate amplifications and/or show stronger activation this receptor. In addition, identified series genes associated with vesicular trafficking gliomas. Among genes, TMEM167A showed strongest implication overall survival group tumors. agreement observation, inhibition expression impaired subcutaneous intracranial growth regardless presence mutations. absence mutations, knockdown reduced acidification intracellular vesicles, affecting autophagy process impairing signaling. This effect was mimicked by an inhibitor vacuolar ATPase. propose increased aggressiveness might be due to increase factor signaling activity, which depends on regulation TMEM167A.

参考文章(34)
Laura Braccini, Elisa Ciraolo, Carlo C. Campa, Alessia Perino, Dario L. Longo, Gianpaolo Tibolla, Marco Pregnolato, Yanyan Cao, Beatrice Tassone, Federico Damilano, Muriel Laffargue, Enzo Calautti, Marco Falasca, Giuseppe D. Norata, Jonathan M. Backer, Emilio Hirsch, PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling Nature Communications. ,vol. 6, pp. 7400- 7400 ,(2015) , 10.1038/NCOMMS8400
Andrea Di Cristofori, Stefano Ferrero, Irene Bertolini, Gabriella Gaudioso, Maria Veronica Russo, Valeria Berno, Marco Vanini, Marco Locatelli, Mario Zavanone, Paolo Rampini, Thomas Vaccari, Manuela Caroli, Valentina Vaira, The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma Oncotarget. ,vol. 6, pp. 17514- 17531 ,(2015) , 10.18632/ONCOTARGET.4239
Cancer Genome Atlas Research Network, None, Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. ,vol. 372, pp. 2481- 2498 ,(2015) , 10.1056/NEJMOA1402121
Cristina Zahonero, Pilar Aguilera, Carmen Ramírez-Castillejo, Marta Pajares, Maria Victoria Bolós, Diana Cantero, Angel Perez-Nuñez, Aurelio Hernández-Laín, Pilar Sánchez-Gómez, Juan Manuel Sepúlveda, Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma Molecular Cancer Therapeutics. ,vol. 14, pp. 1548- 1558 ,(2015) , 10.1158/1535-7163.MCT-14-0736
Igor Vivanco, H. Ian Robins, Daniel Rohle, Carl Campos, Christian Grommes, Phioanh Leia Nghiemphu, Sara Kubek, Barbara Oldrini, Milan G. Chheda, Nicolas Yannuzzi, Hui Tao, Shaojun Zhu, Akio Iwanami, Daisuke Kuga, Julie Dang, Alicia Pedraza, Cameron W. Brennan, Adriana Heguy, Linda M. Liau, Frank Lieberman, W. K. Alfred Yung, Mark R. Gilbert, David A. Reardon, Jan Drappatz, Patrick Y. Wen, Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados, Howard A. Fine, Steve Horvath, Nian Wu, Andrew B. Lassman, Lisa M. DeAngelis, William H. Yong, John G. Kuhn, Paul S. Mischel, Minesh P. Mehta, Timothy F. Cloughesy, Ingo K. Mellinghoff, Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors Cancer Discovery. ,vol. 2, pp. 458- 471 ,(2012) , 10.1158/2159-8290.CD-11-0284
Patricia A.J. Muller, Karen H. Vousden, Mutant p53 in Cancer: New Functions and Therapeutic Opportunities Cancer Cell. ,vol. 25, pp. 304- 317 ,(2014) , 10.1016/J.CCR.2014.01.021
Tatsuya Ozawa, Markus Riester, Yu-Kang Cheng, Jason T. Huse, Massimo Squatrito, Karim Helmy, Nikki Charles, Franziska Michor, Eric C. Holland, Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma Cancer Cell. ,vol. 26, pp. 288- 300 ,(2014) , 10.1016/J.CCR.2014.06.005
Franz Wendler, Alison K Gillingham, Rita Sinka, Cláudia Rosa-Ferreira, David E Gordon, Xavier Franch-Marro, Andrew A Peden, Jean-Paul Vincent, Sean Munro, A genome-wide RNA interference screen identifies two novel components of the metazoan secretory pathway The EMBO Journal. ,vol. 29, pp. 304- 314 ,(2010) , 10.1038/EMBOJ.2009.350
Frank B. Furnari, Timothy F. Cloughesy, Webster K. Cavenee, Paul S. Mischel, Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma Nature Reviews Cancer. ,vol. 15, pp. 302- 310 ,(2015) , 10.1038/NRC3918
Cristina Zahonero, Pilar Sánchez-Gómez, EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy Cellular and Molecular Life Sciences. ,vol. 71, pp. 3465- 3488 ,(2014) , 10.1007/S00018-014-1608-1